Coronavirus Disease

(COVID-19)

Statement from RSC BMCS Committee

14th September 2020
 

With the ongoing Coronavirus situation and as a result of RSC recommendations, the RSC BMCS Committee has decided to hold all events during the first half of 2021 as virtual only. Arrangements for these symposia are under review and these events have been temporarily removed from the schedule until the new arrangements have been agreed. These will be notified in due course.

Please check www.rscbmcs.org and our social media outlets (Twitter @RSC_BMCS, LinkedIn, Facebook and Instagram @RSCBMCS, YouTube) for any updates. 

For current information regarding the virus, please refer to the websites of the UK Government and Public Health England, or the World Health Organisation. 

Hosting BMCS Lectures

We invite both universities & companies to apply to host virtual Lectureship presentations. All three of our Lecturers (below) will deliver talks until Autumn 2022. Relatively small university seminars purely for research students and PDRAs will be considered.

Representative lecture titles will be:
 

Elisabetta Chiarparin, AstraZeneca:  Building the right small molecule in oncology target-based drug discovery
 

James Duffy, Medicines for Malaria Venture:  Antimalarial drug discovery: what have we learnt and what can we achieve?

David Rees, Astex Pharmaceuticals:  Fragment-based drug discovery

Contact:  Initially please write to Dr Andrew Stachulski.

BMCS Initiatives

and Social Media

December 2020 e-alert

Hall of Fame and Medal 2020 Announcement of Inductee